Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-12

Clinical Trial Update: Evaluation of Liquid vs. Tablet Buprenorphine - 6 [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing liquid versus tablet buprenorphine formulations for opioid use disorders has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Buprenorphine (oral solution) (buprenorphine)
  • Buprenorphine (tablet) (buprenorphine)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Opioid-Related Disorders | Phase 2 | Status: COMPLETED